{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:33:59Z","timestamp":1648895639840},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.2515\/therapie:2005085","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T05:45:14Z","timestamp":1173764714000},"page":"593-595","source":"Crossref","is-referenced-by-count":0,"title":["Urticaire cholinergique r\u00e9v\u00e9l\u00e9e par les \u03b2-bloquants : \u00e0 propos d\u2019un cas et de sa prise en charge th\u00e9rapeutique"],"prefix":"10.1016","volume":"60","author":[{"given":"Anne","family":"Chiffoleau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwena\u00eblle","family":"Veyrac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Chavigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Jolliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2005085_bb0815","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on \u03b2-adrenergic receptors blockers. The task force on beta-blockers of the European Society of Cardiology","volume":"25","author":"Lopez-Sendon","year":"2004","journal-title":"Eur Heart J"},{"key":"10.2515\/therapie:2005085_bb0820","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1067\/mai.2002.126811","article-title":"Anaphylaxis: a review of cause and mechanisms","volume":"110","author":"Kemp","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.2515\/therapie:2005085_bb0825","first-page":"191","article-title":"Beta-blocker therapy in cholinergic urticaria [letter]","volume":"107","author":"Ammann","year":"1999","journal-title":"Am J Med"},{"key":"10.2515\/therapie:2005085_bb0830","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/000331970205300617","article-title":"Beta-blockers induced psoriasis, a rare side effect: a case report","volume":"53","author":"Yalmaz","year":"2002","journal-title":"Angiology"},{"key":"10.2515\/therapie:2005085_bb0835","first-page":"217","article-title":"Contact dermatitis to topical drugs for glaucoma","volume":"12","author":"Holdiness","year":"2001","journal-title":"Am J Contact Dermat"},{"key":"10.2515\/therapie:2005085_bb0840","first-page":"365","article-title":"Failure of patch testing with levubunolol eye-drops to detect contact allergy","volume":"43","author":"Statham","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.2515\/therapie:2005085_bb0845","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1365-4362.2000.00819-3.x","article-title":"Bullous pemphigoid possibly triggered and exacerbated by ophtalmic preparations","volume":"39","author":"Spivak","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.2515\/therapie:2005085_bb0850","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1526-4610.1999.3910758.x","article-title":"Severe acne as a side effect of propranolol and nadolol in a migraineur","volume":"39","author":"Bajwa","year":"1999","journal-title":"Headache"},{"key":"10.2515\/therapie:2005085_bb0855","first-page":"1158","article-title":"Fixed drug eruption due to atenolol: a case report","volume":"82","author":"Palungwachira","year":"1999","journal-title":"J Med Assoc Thai"},{"key":"10.2515\/therapie:2005085_bb0860","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1378\/chest.106.6.1922","article-title":"Angioderma following the intravenous administration of metoprolol","volume":"106","author":"Krikorian","year":"1994","journal-title":"Chest"},{"key":"10.2515\/therapie:2005085_bb0865","first-page":"203","article-title":"Urticarial anaphylactoid reaction following metoprolol [letter]","volume":"47","author":"Mora-Fernandez","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.2515\/therapie:2005085_bb0870","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1378\/chest.67.4.496","article-title":"Propranolol-induced urticaria: successful therapy with tolamolol","volume":"67","author":"Seides","year":"1975","journal-title":"Chest"},{"key":"10.2515\/therapie:2005085_bb0875","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1527-5299.2002.01529.x","article-title":"Angiodema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy","volume":"8","author":"Sica","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.2515\/therapie:2005085_bb0880","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/archinte.163.12.1488-a","article-title":"Literature reports of angiotensin receptor antagonist-induced angioedema in patients with a history of angiotensin-converting enzyme inhibitor-induced angioedema","volume":"163","author":"Flais","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie:2005085_bb0885","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1C520","article-title":"Valsartan-induced angioedema","volume":"37","author":"Irons","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.2515\/therapie:2005085_bb0890","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bmj.328.7430.25","article-title":"Rash and acute nephritic syndrome due to candesartan","volume":"328","author":"Morton","year":"2004","journal-title":"BMJ"},{"key":"10.2515\/therapie:2005085_bb0895","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.0000153269.07762.3B","article-title":"Losartan increases bradykinin levels in hypertensive humans","volume":"111","author":"Campbell","year":"2005","journal-title":"Circulation"},{"key":"10.2515\/therapie:2005085_bb0900","first-page":"1S16","article-title":"Urticaires physiques. Conf\u00e9rence de consensus, texte des experts","volume":"130","author":"Barbaud","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.2515\/therapie:2005085_bb0905","first-page":"1S31","article-title":"Urticaires chroniques d\u2019origine m\u00e9dicamenteuse. Conf\u00e9rence de consensus, texte des experts","volume":"130","author":"Mathelier-Fusade","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.2515\/therapie:2005085_bb0910","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments : actualisation de la m\u00e9thode utilis\u00e9e en France","volume":"40","author":"Begaud","year":"1985","journal-title":"Therapie"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T02:57:59Z","timestamp":1554260279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716303468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0040595716303468"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2005085","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}